{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:53Z","timestamp":1792785053956,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Animal Health and Disease Research Program, Auburn University","id":[{"id":"https:\/\/ror.org\/02v80fc35","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61695-0","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:54:45Z","timestamp":1783749285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles from inflammatory-primed stromal cells reduce in vitro inflammation in Sandhoff disease model"],"prefix":"10.1038","volume":"16","author":[{"given":"Nikolia","family":"Darzenta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melikasadat","family":"Mollabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savanie","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Naskou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"61695_CR1","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1038\/s41467-025-63237-0","volume":"16","author":"KI Tsourmas","year":"2025","unstructured":"Tsourmas, K. I. et al. Microglial replacement in a Sandhoff disease mouse model reveals myeloid-derived beta-hexosaminidase is necessary for neuronal health. Nat. Commun. 16, 7994. https:\/\/doi.org\/10.1038\/s41467-025-63237-0 (2025).","journal-title":"Nat. Commun."},{"key":"61695_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neuroscience.2016.10.047","volume":"340","author":"AM Bradbury","year":"2017","unstructured":"Bradbury, A. M. et al. AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease. Neuroscience 340, 117\u2013125. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.10.047 (2017).","journal-title":"Neuroscience"},{"key":"61695_CR3","doi-asserted-by":"publisher","first-page":"136195","DOI":"10.1016\/j.neulet.2021.136195","volume":"764","author":"C Toro","year":"2021","unstructured":"Toro, C., Zainab, M. & Tifft, C. J. The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment. Neurosci. Lett. 764, 136195. https:\/\/doi.org\/10.1016\/j.neulet.2021.136195 (2021).","journal-title":"Neurosci. Lett."},{"key":"61695_CR4","doi-asserted-by":"publisher","unstructured":"Leal, A. F. et al. GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21176213 (2020).","DOI":"10.3390\/ijms21176213"},{"key":"61695_CR5","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1038\/s41591-025-03822-4","volume":"31","author":"F Eichler","year":"2025","unstructured":"Eichler, F. et al. Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1\/2 trial. Nat. Med. 31, 2927\u20132935. https:\/\/doi.org\/10.1038\/s41591-025-03822-4 (2025).","journal-title":"Nat. Med."},{"key":"61695_CR6","doi-asserted-by":"publisher","unstructured":"Rockwell, H. E. et al. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro. 7 https:\/\/doi.org\/10.1177\/1759091415569908 (2015).","DOI":"10.1177\/1759091415569908"},{"key":"61695_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41434-020-00190-1","volume":"28","author":"VJ McCurdy","year":"2021","unstructured":"McCurdy, V. J. et al. Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease. Gene Ther. 28, 142\u2013154. https:\/\/doi.org\/10.1038\/s41434-020-00190-1 (2021).","journal-title":"Gene Ther."},{"key":"61695_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/mt.2013.86","volume":"21","author":"AM Bradbury","year":"2013","unstructured":"Bradbury, A. M. et al. Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy. Mol. Ther. 21, 1306\u20131315. https:\/\/doi.org\/10.1038\/mt.2013.86 (2013).","journal-title":"Mol. Ther."},{"key":"61695_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/ana.26756","volume":"94","author":"AK Johnson","year":"2023","unstructured":"Johnson, A. K. et al. Life-Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy. Ann. Neurol. 94, 969\u2013986. https:\/\/doi.org\/10.1002\/ana.26756 (2023).","journal-title":"Ann. Neurol."},{"key":"61695_CR10","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41586-025-09477-y","volume":"646","author":"M Frosch","year":"2025","unstructured":"Frosch, M. et al. Microglia-neuron crosstalk through Hex-GM2-MGL2 maintains brain homeostasis. Nature 646, 913\u2013924. https:\/\/doi.org\/10.1038\/s41586-025-09477-y (2025).","journal-title":"Nature"},{"key":"61695_CR11","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41586-025-09461-6","volume":"646","author":"MM Mader","year":"2025","unstructured":"Mader, M. M. et al. Therapeutic genetic restoration through allogeneic brain microglia replacement. Nature 646, 903\u2013912. https:\/\/doi.org\/10.1038\/s41586-025-09461-6 (2025).","journal-title":"Nature"},{"key":"61695_CR12","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu, A., Li, S., Gao, F. & Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front. Aging Neurosci. 16, 1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"61695_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/imm.12233","volume":"142","author":"S Amor","year":"2014","unstructured":"Amor, S. et al. Inflammation in neurodegenerative diseases\u2013an update. Immunology 142, 151\u2013166. https:\/\/doi.org\/10.1111\/imm.12233 (2014).","journal-title":"Immunology"},{"key":"61695_CR14","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/brain\/awg089","volume":"126","author":"M Jeyakumar","year":"2003","unstructured":"Jeyakumar, M. et al. Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126, 974\u2013987. https:\/\/doi.org\/10.1093\/brain\/awg089 (2003).","journal-title":"Brain"},{"key":"61695_CR15","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","volume":"97","author":"R Wada","year":"2000","unstructured":"Wada, R., Tifft, C. J. & Proia, R. L. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. U. S. A. 97, 10954\u201310959. https:\/\/doi.org\/10.1073\/pnas.97.20.10954 (2000).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"61695_CR16","doi-asserted-by":"publisher","first-page":"40518","DOI":"10.1038\/srep40518","volume":"7","author":"Y Ogawa","year":"2017","unstructured":"Ogawa, Y. et al. FcRgamma-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice. Sci. Rep. 7, 40518. https:\/\/doi.org\/10.1038\/srep40518 (2017).","journal-title":"Sci. Rep."},{"key":"61695_CR17","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ana.20242","volume":"56","author":"M Jeyakumar","year":"2004","unstructured":"Jeyakumar, M. et al. NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann. Neurol. 56, 642\u2013649. https:\/\/doi.org\/10.1002\/ana.20242 (2004).","journal-title":"Ann. Neurol."},{"key":"61695_CR18","doi-asserted-by":"publisher","first-page":"8425","DOI":"10.1073\/pnas.0400625101","volume":"101","author":"YP Wu","year":"2004","unstructured":"Wu, Y. P. & Proia, R. L. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice. Proc. Natl. Acad. Sci. U. S. A. 101, 8425\u20138430. https:\/\/doi.org\/10.1073\/pnas.0400625101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"61695_CR19","unstructured":"Maguire, A. S. Myelin Deficits and Intravenous Gene Therapy in Feline Sandhoff Disease (Auburn University, 2021)."},{"key":"61695_CR20","doi-asserted-by":"publisher","unstructured":"Maguire, A. S. et al. Intravenous gene therapy improves lifespan and clinical outcomes in feline Sandhoff Disease. bioRxiv https:\/\/doi.org\/10.1101\/2024.11.15.623838 (2024).","DOI":"10.1101\/2024.11.15.623838"},{"key":"61695_CR21","doi-asserted-by":"publisher","first-page":"eadx0043","DOI":"10.1126\/science.adx0043","volume":"388","author":"FD Shi","year":"2025","unstructured":"Shi, F. D. & Yong, V. W. Neuroinflammation across neurological diseases. Science 388, eadx0043. https:\/\/doi.org\/10.1126\/science.adx0043 (2025).","journal-title":"Science"},{"key":"61695_CR22","doi-asserted-by":"publisher","unstructured":"Freyermuth-Trujillo, X., Segura-Uribe, J. J., Salgado-Ceballos, H., Orozco-Barrios, C. E. & Coyoy-Salgado, A. Inflammation: a target for treatment in spinal cord injury. Cells 11 https:\/\/doi.org\/10.3390\/cells11172692 (2022).","DOI":"10.3390\/cells11172692"},{"key":"61695_CR23","doi-asserted-by":"publisher","first-page":"174800","DOI":"10.1016\/j.ejphar.2022.174800","volume":"919","author":"BD Arbo","year":"2022","unstructured":"Arbo, B. D., Schimith, L. E., Goulart Dos Santos, M. & Hort, M. A. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation. Eur. J. Pharmacol. 919, 174800. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174800 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"61695_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12017-023-08741-6","volume":"25","author":"B Wiatrak","year":"2023","unstructured":"Wiatrak, B., Jawien, P., Szelag, A. & Jeskowiak-Kossakowska, I. Does Inflammation Play a Major Role in the Pathogenesis of Alzheimer\u2019s Disease? Neuromolecular Med. 25, 330\u2013335. https:\/\/doi.org\/10.1007\/s12017-023-08741-6 (2023).","journal-title":"Neuromolecular Med."},{"key":"61695_CR25","doi-asserted-by":"publisher","first-page":"fcaa109","DOI":"10.1093\/braincomms\/fcaa109","volume":"2","author":"J Rivers-Auty","year":"2020","unstructured":"Rivers-Auty, J., Mather, A. E., Peters, R., Lawrence, C. B. & Brough, D. Anti-inflammatories in Alzheimer\u2019s disease-potential therapy or spurious correlate? Brain Commun. 2, fcaa109. https:\/\/doi.org\/10.1093\/braincomms\/fcaa109 (2020).","journal-title":"Brain Commun."},{"key":"61695_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.18433\/j3vw2f","volume":"16","author":"S Harirforoosh","year":"2013","unstructured":"Harirforoosh, S., Asghar, W. & Jamali, F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J. Pharm. Pharm. Sci. 16, 821\u2013847. https:\/\/doi.org\/10.18433\/j3vw2f (2013).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"61695_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/187152312803476255","volume":"11","author":"S Bacchi","year":"2012","unstructured":"Bacchi, S., Palumbo, P., Sponta, A. & Coppolino, M. F. Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Antiinflamm Antiallergy Agents Med. Chem. 11, 52\u201364. https:\/\/doi.org\/10.2174\/187152312803476255 (2012).","journal-title":"Antiinflamm Antiallergy Agents Med. Chem."},{"key":"61695_CR28","doi-asserted-by":"publisher","unstructured":"Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N. & Volarevic, V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells 8 https:\/\/doi.org\/10.3390\/cells8121605 (2019).","DOI":"10.3390\/cells8121605"},{"key":"61695_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jconrel.2023.03.009","volume":"356","author":"L Nieland","year":"2023","unstructured":"Nieland, L., Mahjoum, S., Grandell, E., Breyne, K. & Breakefield, X. O. Engineered EVs designed to target diseases of the CNS. J. Control Release. 356, 493\u2013506. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.009 (2023).","journal-title":"J. Control Release"},{"key":"61695_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney, D. G., Pittenger, M. F. & Concise Review MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells. 35, 851\u2013858. https:\/\/doi.org\/10.1002\/stem.2575 (2017).","journal-title":"Stem Cells"},{"key":"61695_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s12975-017-0599-2","volume":"9","author":"RL Webb","year":"2018","unstructured":"Webb, R. L. et al. Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model. Transl Stroke Res. 9, 530\u2013539. https:\/\/doi.org\/10.1007\/s12975-017-0599-2 (2018).","journal-title":"Transl Stroke Res."},{"key":"61695_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40364-019-0156-0","volume":"7","author":"P Lai","year":"2019","unstructured":"Lai, P., Weng, J., Guo, L., Chen, X. & Du, X. Novel insights into MSC-EVs therapy for immune diseases. Biomark. Res. 7, 6. https:\/\/doi.org\/10.1186\/s40364-019-0156-0 (2019).","journal-title":"Biomark. Res."},{"key":"61695_CR33","doi-asserted-by":"publisher","first-page":"10740","DOI":"10.1038\/s41598-020-67563-9","volume":"10","author":"MO Gomzikova","year":"2020","unstructured":"Gomzikova, M. O. et al. Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells. Sci. Rep. 10, 10740. https:\/\/doi.org\/10.1038\/s41598-020-67563-9 (2020).","journal-title":"Sci. Rep."},{"key":"61695_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12929-024-01075-w","volume":"31","author":"N Putthanbut","year":"2024","unstructured":"Putthanbut, N., Lee, J. Y. & Borlongan, C. V. Extracellular vesicle therapy in neurological disorders. J. Biomed. Sci. 31, 85. https:\/\/doi.org\/10.1186\/s12929-024-01075-w (2024).","journal-title":"J. Biomed. Sci."},{"key":"61695_CR35","doi-asserted-by":"publisher","unstructured":"Andjus, P. et al. Extracellular vesicles as innovative tool for diagnosis, regeneration and protection against neurological damage. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21186859 (2020).","DOI":"10.3390\/ijms21186859"},{"key":"61695_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41598-017-18867-w","volume":"8","author":"KA Ruppert","year":"2018","unstructured":"Ruppert, K. A. et al. Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Modify Microglial Response and Improve Clinical Outcomes in Experimental Spinal Cord Injury. Sci. Rep. 8, 480. https:\/\/doi.org\/10.1038\/s41598-017-18867-w (2018).","journal-title":"Sci. Rep."},{"key":"61695_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fimmu.2020.00013","volume":"11","author":"M Xie","year":"2020","unstructured":"Xie, M. et al. Immunoregulatory Effects of Stem Cell-Derived Extracellular Vesicles on Immune Cells. Front. Immunol. 11, 13. https:\/\/doi.org\/10.3389\/fimmu.2020.00013 (2020).","journal-title":"Front. Immunol."},{"key":"61695_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12974-022-02445-7","volume":"19","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Extracellular vesicles derived from mesenchymal stem cells alleviate neuroinflammation and mechanical allodynia in interstitial cystitis rats by inhibiting NLRP3 inflammasome activation. J. Neuroinflammation. 19, 80. https:\/\/doi.org\/10.1186\/s12974-022-02445-7 (2022).","journal-title":"J. Neuroinflammation"},{"key":"61695_CR39","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s11064-018-2641-5","volume":"43","author":"M Ding","year":"2018","unstructured":"Ding, M. et al. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer\u2019s Disease. Neurochem Res. 43, 2165\u20132177. https:\/\/doi.org\/10.1007\/s11064-018-2641-5 (2018).","journal-title":"Neurochem Res."},{"key":"61695_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.yexcr.2015.12.009","volume":"340","author":"R Bonafede","year":"2016","unstructured":"Bonafede, R. et al. Exosome derived from murine adipose-derived stromal cells: Neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp. Cell. Res. 340, 150\u2013158. https:\/\/doi.org\/10.1016\/j.yexcr.2015.12.009 (2016).","journal-title":"Exp. Cell. Res."},{"key":"61695_CR41","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41598-022-06824-1","volume":"12","author":"JS Heo","year":"2022","unstructured":"Heo, J. S. & Kim, S. Human adipose mesenchymal stem cells modulate inflammation and angiogenesis through exosomes. Sci. Rep. 12, 2776. https:\/\/doi.org\/10.1038\/s41598-022-06824-1 (2022).","journal-title":"Sci. Rep."},{"key":"61695_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13287-019-1207-z","volume":"10","author":"G Thomi","year":"2019","unstructured":"Thomi, G., Surbek, D., Haesler, V., Joerger-Messerli, M. & Schoeberlein, A. Exosomes derived from umbilical cord mesenchymal stem cells reduce microglia-mediated neuroinflammation in perinatal brain injury. Stem Cell. Res. Ther. 10, 105. https:\/\/doi.org\/10.1186\/s13287-019-1207-z (2019).","journal-title":"Stem Cell. Res. Ther."},{"key":"61695_CR43","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1038\/s41598-021-81039-4","volume":"11","author":"D Giunti","year":"2021","unstructured":"Giunti, D. et al. Role of miRNAs shuttled by mesenchymal stem cell-derived small extracellular vesicles in modulating neuroinflammation. Sci. Rep. 11, 1740. https:\/\/doi.org\/10.1038\/s41598-021-81039-4 (2021).","journal-title":"Sci. Rep."},{"key":"61695_CR44","doi-asserted-by":"publisher","first-page":"151921","DOI":"10.1016\/j.aanat.2022.151921","volume":"242","author":"Y Ding","year":"2022","unstructured":"Ding, Y., Botchway, B. O. A., Zhang, Y., Jin, T. & Liu, X. The combination of autologous mesenchymal stem cell-derived exosomes and neurotrophic factors as an intervention for amyotrophic lateral sclerosis. Ann. Anat. 242, 151921. https:\/\/doi.org\/10.1016\/j.aanat.2022.151921 (2022).","journal-title":"Ann. Anat."},{"key":"61695_CR45","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ymthe.2021.08.008","volume":"30","author":"E Markoutsa","year":"2022","unstructured":"Markoutsa, E., Mayilsamy, K., Gulick, D., Mohapatra, S. S. & Mohapatra, S. Extracellular vesicles derived from inflammatory-educated stem cells reverse brain inflammation-implication of miRNAs. Mol. Ther. 30, 816\u2013830. https:\/\/doi.org\/10.1016\/j.ymthe.2021.08.008 (2022).","journal-title":"Mol. Ther."},{"key":"61695_CR46","doi-asserted-by":"publisher","first-page":"13325","DOI":"10.1038\/s41598-018-31707-9","volume":"8","author":"R Domenis","year":"2018","unstructured":"Domenis, R. et al. Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes. Sci. Rep. 8, 13325. https:\/\/doi.org\/10.1038\/s41598-018-31707-9 (2018).","journal-title":"Sci. Rep."},{"key":"61695_CR47","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1021\/acsnano.9b01004","volume":"13","author":"M Riazifar","year":"2019","unstructured":"Riazifar, M. et al. Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders. ACS Nano. 13, 6670\u20136688. https:\/\/doi.org\/10.1021\/acsnano.9b01004 (2019).","journal-title":"ACS Nano"},{"key":"61695_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/scd.2023.0229","volume":"33","author":"MC Naskou","year":"2024","unstructured":"Naskou, M. C. et al. The Characteristics and Function of Small Extracellular Vesicles Derived from Human Bone Marrow and Umbilical Cord Mesenchymal Stromal Cells Are Influenced by Cell Culture Conditions. Stem Cells Dev. 33, 117\u2013127. https:\/\/doi.org\/10.1089\/scd.2023.0229 (2024).","journal-title":"Stem Cells Dev."},{"key":"61695_CR49","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.regen.2020.100036","volume":"13","author":"S Andrews","year":"2021","unstructured":"Andrews, S., Maughon, T., Marklein, R. & Stice, S. Priming of MSCs with inflammation-relevant signals affects extracellular vesicle biogenesis, surface markers, and modulation of T cell subsets. J. Immunol. Regenerative Med. 13, 100036. https:\/\/doi.org\/10.1016\/j.regen.2020.100036 (2021).","journal-title":"J. Immunol. Regenerative Med."},{"key":"61695_CR50","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/ALN.0000000000002655","volume":"130","author":"AK Varkouhi","year":"2019","unstructured":"Varkouhi, A. K. et al. Extracellular Vesicles from Interferon-gamma-primed Human Umbilical Cord Mesenchymal Stromal Cells Reduce Escherichia coli-induced Acute Lung Injury in Rats. Anesthesiology 130, 778\u2013790. https:\/\/doi.org\/10.1097\/ALN.0000000000002655 (2019).","journal-title":"Anesthesiology"},{"key":"61695_CR51","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song, N., Scholtemeijer, M. & Shah, K. Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. Trends Pharmacol. Sci. 41, 653\u2013664. https:\/\/doi.org\/10.1016\/j.tips.2020.06.009 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"61695_CR52","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/scd.2025.0042","volume":"34","author":"N Darzenta","year":"2025","unstructured":"Darzenta, N. et al. Extracellular Vesicles from Mesenchymal Stromal Cells Modulate Inflammatory Responses on Feline Mixed Glia. Stem Cells Dev. 34, 343\u2013356. https:\/\/doi.org\/10.1089\/scd.2025.0042 (2025).","journal-title":"Stem Cells Dev."},{"key":"61695_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11745-008-3268-0","volume":"44","author":"RC Baek","year":"2009","unstructured":"Baek, R. C., Martin, D. R., Cox, N. R. & Seyfried, T. N. Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease. Lipids 44, 197\u2013205. https:\/\/doi.org\/10.1007\/s11745-008-3268-0 (2009).","journal-title":"Lipids"},{"key":"61695_CR54","doi-asserted-by":"publisher","first-page":"676621","DOI":"10.3389\/fimmu.2021.676621","volume":"12","author":"AP Passaro","year":"2021","unstructured":"Passaro, A. P., Lebos, A. L., Yao, Y. & Stice, S. L. Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk. Front. Immunol. 12, 676621. https:\/\/doi.org\/10.3389\/fimmu.2021.676621 (2021).","journal-title":"Front. Immunol."},{"key":"61695_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2008.06.024","volume":"203","author":"S Kyrkanides","year":"2008","unstructured":"Kyrkanides, S. et al. Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-\/- mouse model of neurodegeneration. J. Neuroimmunol. 203, 50\u201357. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.024 (2008).","journal-title":"J. Neuroimmunol."},{"key":"61695_CR56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.vetimm.2004.01.002","volume":"99","author":"VM Stein","year":"2004","unstructured":"Stein, V. M. et al. Characterization of canine microglial cells isolated ex vivo. Vet. Immunol. Immunopathol. 99, 73\u201385. https:\/\/doi.org\/10.1016\/j.vetimm.2004.01.002 (2004).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"61695_CR57","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/NEN.0b013e31825414a6","volume":"71","author":"VM Stein","year":"2012","unstructured":"Stein, V. M. et al. Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C. J. Neuropathol. Exp. Neurol. 71, 434\u2013448. https:\/\/doi.org\/10.1097\/NEN.0b013e31825414a6 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"61695_CR58","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell. Vesicles. 13, e12404. https:\/\/doi.org\/10.1002\/jev2.12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"61695_CR59","doi-asserted-by":"publisher","first-page":"100816","DOI":"10.1016\/j.bbih.2024.100816","volume":"39","author":"KA Lawrence","year":"2024","unstructured":"Lawrence, K. A., Gloger, E. M., Pinheiro, C. N., Schmitt, F. A. & Segerstrom, S. C. Associations between IL-1beta, IL-6, and TNFalpha polymorphisms and longitudinal trajectories of cognitive function in non-demented older adults. Brain Behav. Immun. Health. 39, 100816. https:\/\/doi.org\/10.1016\/j.bbih.2024.100816 (2024).","journal-title":"Brain Behav. Immun. Health"},{"key":"61695_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.vetmic.2013.01.042","volume":"164","author":"BL Vermeulen","year":"2013","unstructured":"Vermeulen, B. L. et al. Suppression of NK cells and regulatory T lymphocytes in cats naturally infected with feline infectious peritonitis virus. Vet. Microbiol. 164, 46\u201359. https:\/\/doi.org\/10.1016\/j.vetmic.2013.01.042 (2013).","journal-title":"Vet. Microbiol."},{"key":"61695_CR61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.braindev.2009.01.007","volume":"32","author":"T Hayase","year":"2010","unstructured":"Hayase, T. et al. Unilaterally and rapidly progressing white matter lesion and elevated cytokines in a patient with Tay-Sachs disease. Brain Dev. 32, 244\u2013247. https:\/\/doi.org\/10.1016\/j.braindev.2009.01.007 (2010).","journal-title":"Brain Dev."},{"key":"61695_CR62","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ymgme.2014.11.015","volume":"114","author":"JR Utz","year":"2015","unstructured":"Utz, J. R., Crutcher, T., Schneider, J., Sorgen, P. & Whitley, C. B. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses. Mol. Genet. Metab. 114, 274\u2013280. https:\/\/doi.org\/10.1016\/j.ymgme.2014.11.015 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"61695_CR63","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1172\/JCI19639","volume":"113","author":"A Yamaguchi","year":"2004","unstructured":"Yamaguchi, A. et al. Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. J. Clin. Invest. 113, 200\u2013208. https:\/\/doi.org\/10.1172\/JCI19639 (2004).","journal-title":"J. Clin. Invest."},{"key":"61695_CR64","doi-asserted-by":"publisher","unstructured":"Soltero-Rivera, M., Arzi, B., Bourebaba, L. & Marycz, K. Impact of pro-inflammatory cytokine preconditioning on metabolism and extracellular vesicles in feline mesenchymal stromal cells: a preliminary study. Stem Cells. 43 https:\/\/doi.org\/10.1093\/stmcls\/sxaf014 (2025).","DOI":"10.1093\/stmcls\/sxaf014"},{"key":"61695_CR65","doi-asserted-by":"publisher","unstructured":"Turano, E. et al. Adipose mesenchymal stem cells-derived extracellular vesicles exert their preferential action in damaged central sites of SOD1 mice rather than peripherally. Eur. J. Histochem. 68 https:\/\/doi.org\/10.4081\/ejh.2024.4040 (2024).","DOI":"10.4081\/ejh.2024.4040"},{"key":"61695_CR66","doi-asserted-by":"publisher","unstructured":"Bonafede, R. et al. ASC-exosomes ameliorate the disease progression in SOD1(G93A) murine model underlining their potential therapeutic use in human ALS. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21103651 (2020).","DOI":"10.3390\/ijms21103651"},{"key":"61695_CR67","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4103\/NRR.NRR-D-23-01815","volume":"20","author":"PJ Goldschmidt-Clermont","year":"2025","unstructured":"Goldschmidt-Clermont, P. J. et al. Treating amyotrophic lateral sclerosis with allogeneic Schwann cell-derived exosomal vesicles: a case report. Neural Regen Res. 20, 1207\u20131216. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01815 (2025).","journal-title":"Neural Regen Res."},{"key":"61695_CR68","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal. Transduct. Target. Ther. 8, 267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"61695_CR69","doi-asserted-by":"publisher","unstructured":"Pandey, M. K. Exploring pro-inflammatory immunological mediators: unraveling the mechanisms of neuroinflammation in lysosomal storage diseases. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11041067 (2023).","DOI":"10.3390\/biomedicines11041067"},{"key":"61695_CR70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang, W. Y., Tan, M. S., Yu, J. T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann. Transl Med. 3, 136. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49 (2015).","journal-title":"Ann. Transl Med."},{"key":"61695_CR71","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41419-023-06147-7","volume":"14","author":"E Shosha","year":"2023","unstructured":"Shosha, E. et al. The arginase 1\/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury. Cell. Death Dis. 14, 621. https:\/\/doi.org\/10.1038\/s41419-023-06147-7 (2023).","journal-title":"Cell. Death Dis."},{"key":"61695_CR72","doi-asserted-by":"publisher","unstructured":"Platt, N. et al. Dysregulation of the NLRP3 inflammasome and promotion of disease by IL-1beta in a murine model of sandhoff disease. Cells 14 https:\/\/doi.org\/10.3390\/cells14010035 (2025).","DOI":"10.3390\/cells14010035"},{"key":"61695_CR73","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2022.11.014","volume":"108","author":"M Kodali","year":"2023","unstructured":"Kodali, M. et al. Intranasally administered human MSC-derived extracellular vesicles inhibit NLRP3-p38\/MAPK signaling after TBI and prevent chronic brain dysfunction. Brain Behav. Immun. 108, 118\u2013134. https:\/\/doi.org\/10.1016\/j.bbi.2022.11.014 (2023).","journal-title":"Brain Behav. Immun."},{"key":"61695_CR74","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2460\/javma.24.02.0074","volume":"262","author":"TL Webb","year":"2024","unstructured":"Webb, T. L. & Webb, C. B. Scoping review of the use of mesenchymal stem and stromal cell products in cats, Part 1: current logistics and safety. J. Am. Vet. Med. Assoc. 262, S16\u2013S23. https:\/\/doi.org\/10.2460\/javma.24.02.0074 (2024).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"61695_CR75","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1182\/blood-2013-10-530469","volume":"123","author":"A Danesh","year":"2014","unstructured":"Danesh, A. et al. Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 123, 687\u2013696. https:\/\/doi.org\/10.1182\/blood-2013-10-530469 (2014).","journal-title":"Blood"},{"key":"61695_CR76","doi-asserted-by":"publisher","unstructured":"Kanzaki, S. et al. Thymic alterations in GM2 gangliosidoses model mice. PLoS ONE. 5 https:\/\/doi.org\/10.1371\/journal.pone.0012105 (2010).","DOI":"10.1371\/journal.pone.0012105"},{"key":"61695_CR77","doi-asserted-by":"publisher","first-page":"fcaa112","DOI":"10.1093\/braincomms\/fcaa112","volume":"2","author":"A Faridar","year":"2020","unstructured":"Faridar, A. et al. Restoring regulatory T-cell dysfunction in Alzheimer\u2019s disease through ex vivo expansion. Brain Commun. 2, fcaa112. https:\/\/doi.org\/10.1093\/braincomms\/fcaa112 (2020).","journal-title":"Brain Commun."},{"key":"61695_CR78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-020-00375-7","volume":"15","author":"J Machhi","year":"2020","unstructured":"Machhi, J. et al. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol. Neurodegener. 15, 32. https:\/\/doi.org\/10.1186\/s13024-020-00375-7 (2020).","journal-title":"Mol. Neurodegener"},{"key":"61695_CR79","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fvets.2020.00310","volume":"7","author":"N Vapniarsky","year":"2020","unstructured":"Vapniarsky, N. et al. Histological, Immunological, and Genetic Analysis of Feline Chronic Gingivostomatitis. Front. Vet. Sci. 7, 310. https:\/\/doi.org\/10.3389\/fvets.2020.00310 (2020).","journal-title":"Front. Vet. Sci."},{"key":"61695_CR80","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/stem.3151","volume":"38","author":"N Negi","year":"2020","unstructured":"Negi, N. & Griffin, M. D. Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance. Stem Cells. 38, 596\u2013605. https:\/\/doi.org\/10.1002\/stem.3151 (2020).","journal-title":"Stem Cells"},{"key":"61695_CR81","doi-asserted-by":"publisher","first-page":"596079","DOI":"10.3389\/fcell.2020.596079","volume":"8","author":"R Bazzoni","year":"2020","unstructured":"Bazzoni, R., Takam Kamga, P., Tanasi, I. & Krampera, M. Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells. Front. Cell. Dev. Biol. 8, 596079. https:\/\/doi.org\/10.3389\/fcell.2020.596079 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"61695_CR82","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12917-018-1684-9","volume":"14","author":"JH An","year":"2018","unstructured":"An, J. H. et al. Prostaglandin E(2) secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice. BMC Vet. Res. 14, 354. https:\/\/doi.org\/10.1186\/s12917-018-1684-9 (2018).","journal-title":"BMC Vet. Res."},{"key":"61695_CR83","doi-asserted-by":"publisher","unstructured":"Wanakumjorn, P. et al. Mesenchymal stem\/stromal cell therapy improves immune recovery in a feline model of severe coronavirus infection. Stem Cells Transl. Med. 14 https:\/\/doi.org\/10.1093\/stcltm\/szaf025 (2025).","DOI":"10.1093\/stcltm\/szaf025"},{"key":"61695_CR84","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/sji.13013","volume":"93","author":"H Baharlooi","year":"2021","unstructured":"Baharlooi, H. et al. Umbilical cord mesenchymal stem cells as well as their released exosomes suppress proliferation of activated PBMCs in multiple sclerosis. Scand. J. Immunol. 93, e13013. https:\/\/doi.org\/10.1111\/sji.13013 (2021).","journal-title":"Scand. J. Immunol."},{"key":"61695_CR85","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.3727\/096368915X687543","volume":"24","author":"A Del Fattore","year":"2015","unstructured":"Del Fattore, A. et al. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes. Cell. Transpl. 24, 2615\u20132627. https:\/\/doi.org\/10.3727\/096368915X687543 (2015).","journal-title":"Cell. Transpl."},{"key":"61695_CR86","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1080\/0886022X.2020.1830108","volume":"42","author":"B Packialakshmi","year":"2020","unstructured":"Packialakshmi, B., Stewart, I. J., Burmeister, D. M., Chung, K. K. & Zhou, X. Large animal models for translational research in acute kidney injury. Ren. Fail. 42, 1042\u20131058. https:\/\/doi.org\/10.1080\/0886022X.2020.1830108 (2020).","journal-title":"Ren. Fail."},{"key":"61695_CR87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/gt.2014.108","volume":"22","author":"VJ McCurdy","year":"2015","unstructured":"McCurdy, V. J. et al. Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease. Gene Ther. 22, 181\u2013189. https:\/\/doi.org\/10.1038\/gt.2014.108 (2015).","journal-title":"Gene Ther."},{"key":"61695_CR88","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","volume":"263","author":"AM Bradbury","year":"2015","unstructured":"Bradbury, A. M. et al. Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease. Exp. Neurol. 263, 102\u2013112. https:\/\/doi.org\/10.1016\/j.expneurol.2014.09.020 (2015).","journal-title":"Exp. Neurol."},{"key":"61695_CR89","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/j.1471-4159.2007.05043.x","volume":"104","author":"PJ Darlington","year":"2008","unstructured":"Darlington, P. J., Goldman, J. S., Cui, Q. L., Antel, J. P. & Kennedy, T. E. Widespread immunoreactivity for neuronal nuclei in cultured human and rodent astrocytes. J. Neurochem. 104, 1201\u20131209. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05043.x (2008).","journal-title":"J. Neurochem"},{"key":"61695_CR90","doi-asserted-by":"publisher","first-page":"42","DOI":"10.32607\/20758251-2015-7-2-42-47","volume":"7","author":"VV Gusel\u2019nikova","year":"2015","unstructured":"Gusel\u2019nikova, V. V. & Korzhevskiy, D. E. NeuN As a Neuronal Nuclear Antigen and Neuron Differentiation Marker. Acta Naturae. 7, 42\u201347 (2015).","journal-title":"Acta Naturae"},{"key":"61695_CR91","doi-asserted-by":"publisher","first-page":"e12468","DOI":"10.1002\/jev2.12468","volume":"13","author":"J Duan","year":"2024","unstructured":"Duan, J. et al. Oxidative stress induces extracellular vesicle release by upregulation of HEXB to facilitate tumour growth in experimental hepatocellular carcinoma. J. Extracell. Vesicles. 13, e12468. https:\/\/doi.org\/10.1002\/jev2.12468 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"61695_CR92","doi-asserted-by":"publisher","unstructured":"Calzoni, E. et al. Evidence of lysosomal beta-hexosaminidase enzymatic activity associated with extracellular vesicles: potential applications for the correction of sandhoff disease. J. Funct. Biomater. 15 https:\/\/doi.org\/10.3390\/jfb15060153 (2024).","DOI":"10.3390\/jfb15060153"},{"key":"61695_CR93","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.vetimm.2006.12.002","volume":"116","author":"BJ Biller","year":"2007","unstructured":"Biller, B. J., Elmslie, R. E., Burnett, R. C., Avery, A. C. & Dow, S. W. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet. Immunol. Immunopathol. 116, 69\u201378. https:\/\/doi.org\/10.1016\/j.vetimm.2006.12.002 (2007).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"61695_CR94","doi-asserted-by":"publisher","first-page":"105158","DOI":"10.1016\/j.isci.2022.105158","volume":"25","author":"D Ruiz","year":"2022","unstructured":"Ruiz, D. et al. Development of OX40 agonists for canine cancer immunotherapy. iScience 25, 105158. https:\/\/doi.org\/10.1016\/j.isci.2022.105158 (2022).","journal-title":"iScience"},{"key":"61695_CR95","doi-asserted-by":"publisher","unstructured":"Skrzypczak-Wiercioch, A. & Salat, K. Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use. Molecules 27 https:\/\/doi.org\/10.3390\/molecules27175481 (2022).","DOI":"10.3390\/molecules27175481"},{"key":"61695_CR96","doi-asserted-by":"publisher","first-page":"112292","DOI":"10.1016\/j.intimp.2024.112292","volume":"135","author":"A Bernardette Martinez-Rizo","year":"2024","unstructured":"Bernardette Martinez-Rizo, A. et al. Models in vivo and in vitro for the study of acute and chronic inflammatory activity: A comprehensive review. Int. Immunopharmacol. 135, 112292. https:\/\/doi.org\/10.1016\/j.intimp.2024.112292 (2024).","journal-title":"Int. Immunopharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61695-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:06:59Z","timestamp":1791763619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61695"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61695-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) were purchased commercially from Lifeline Cell Technology (Frederick, MD, USA; Catalog #FC-0020, Lot #01433). Lifeline Cell Technology certifies that the cell donors gave full consent and that the handling and collection of human tissue were conducted in compliance with the Code of Federal Regulations (21 CFR Part 1271), the Declaration of Helsinki and the Health Insurance Portability and Accountability Act (HIPAA) to ensure donor privacy\n                      80\n                      . The use of animals in this study followed the Guidelines for the Euthanasia of Animals (2020) of the American Veterinary Medical Association (AVMA), as well as was an institutionally approved project by the Auburn University Institutional Animal Care and Use Committee (IACUC), entitled \u201cExtracellular Vesicles for the treatment of the Gangliosidoses\u201d (protocol number 2022\u20135082) on 9\/16\/2022.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31821"}}